Skip to main content

Maag Peter's Form 4 filing

CareDx, Inc. (CDNA) · filed Sep 7, 2021

Accession no.
0001217234-21-000210
Filed
Sep 7, 2021
Trade date
Sep 7, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $736.7K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maag PeterCIK 0001613855Director, Officer (Executive Chair)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 7, 2021Common StockMOption exerciseAcquired+925$6.31+$5,836.75349,233Direct
Sep 7, 2021Common StockMOption exerciseAcquired+2,523$12.24+$30,881.52351,756Direct
Sep 7, 2021Common StockSSaleDisposed−8,800$73.55F2−$647,240342,956Direct
Sep 7, 2021Common StockSSaleDisposed−900$74.32F3−$66,888342,056Direct
Sep 7, 2021Common StockSSaleDisposed−300$75.31F4−$22,593341,756Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 7, 2021Common StockMOption exerciseAcquired+925$6.31+$5,836.759,867Direct
Sep 7, 2021Common StockMOption exerciseAcquired+2,523$12.24+$30,881.5228,727Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.10 to $74.055, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.43, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.25 to $75.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)